AID Diagnostika
Private Company
Funding information not available
Overview
AID Diagnostika is a long-established, privately-held diagnostics company focused on immunology and infectious disease testing. It has built a business around manufacturing and selling its own diagnostic kits and complementary imaging/analysis systems, indicating a vertically integrated approach within its niche. The company appears to be in a stable, revenue-generating commercial stage, leveraging its decades of experience in a consistently relevant diagnostic sector. Its private status and specific focus suggest a specialized, steady-state operation rather than a high-growth biotech venture.
Technology Platform
Integrated diagnostic platform combining immunological assay kits (e.g., ELISA, IFA, immunoblot) with proprietary imaging devices and analysis software for end-to-end workflow solutions in clinical laboratories.
Opportunities
Risk Factors
Competitive Landscape
AID Diagnostika competes in a fragmented but competitive segment against giant diversified players (Roche, Abbott, Siemens) and other specialized immunology diagnostics firms. It differentiates through a focused product portfolio, integrated systems, and deep niche expertise, but faces constant pressure from larger competitors' scale and R&D resources.